Benefits of deacetylase inhibitors for leukemia therapy
Rapid responses with targeted agent in Phase I trial for systemic mastocytosis
Molecular genetics and targeting in AML: highlights from ASH 2017
Highlights from ASH 2016: whole-genome sequencing to identify genomic lesions in ALL
Can transplant quality be improved by training medical personnel?